{
  "first_published_at": "2013-09-09", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON314897", 
  "title": "Intravenous iron and serious hypersensitivity reactions: clarification of advice on new recommendations regarding initial test dose", 
  "tags": "{\"parsed_therapeutic\": [\"nutrition-dietetics\", \"obstetrics-gynaecology-fertility\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Nutrition and dietetics\", \"Obstetrics, gynaecology and fertility\"]}", 
  "_document_number": 54, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "nutrition-dietetics", 
    "obstetrics-gynaecology-fertility"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Intravenous iron and serious hypersensitivity reactions: clarification of advice on new recommendations regarding initial test dose</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: September 2013</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--We would like to make you aware that on Sept 9, 2013, we updated the information in the recent intravenous (IV) iron and serious hypersensitivity reactions article published in the August 2013 issue of the bulletin.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>We would like to make you aware that on Sept 9, 2013, we updated the information in the recent <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398\" target=\"_blank\">intravenous (IV) iron and serious hypersensitivity reactions article</a> published in the August 2013 issue of the bulletin. The article advised that an initial test dose on first use of an IV iron product for a new patient is no longer recommended; all references to this recommendation will be removed from relevant product information. However, the article has been updated to clarify that the advice for administration of a product remains otherwise unchanged. For example, for iron dextrans (CosmoFer), a slower rate of administration for the first 25&#160;mg of iron is required for every dose.</p>\n\n<p>The article can be found <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398\" target=\"_blank\">here</a>. If you read, downloaded, or shared the article before the update on Sept 9, 2013, please revisit the article to ensure that you have the most up to date information.</p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update September 2013 volume 7, issue 2: O1.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>We would like to make you aware that on Sept 9, 2013, we updated the information in the recent <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398\" target=\"_blank\">intravenous (IV) iron and serious hypersensitivity reactions article</a> published in the August 2013 issue of the bulletin. The article advised that an initial test dose on first use of an IV iron product for a new patient is no longer recommended; all references to this recommendation will be removed from relevant product information. However, the article has been updated to clarify that the advice for administration of a product remains otherwise unchanged. For example, for iron dextrans (CosmoFer), a slower rate of administration for the first 25&#160;mg of iron is required for every dose.</p>\n\n<p>The article can be found <a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398\" target=\"_blank\">here</a>. If you read, downloaded, or shared the article before the update on Sept 9, 2013, please revisit the article to ensure that you have the most up to date information.</p>\n\n<p>&#160;</p>\n\n<p><em>Article citation: Drug Safety Update September 2013 volume 7, issue 2: O1.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2013-09-01", 
  "date_last_modified": "2013-09-09", 
  "_assets": [], 
  "_item_id": 54, 
  "summary": "", 
  "body": "Article date: September 2013\n\nWe would like to make you aware that on Sept 9, 2013, we updated the information in the recent [intravenous (IV) iron and serious hypersensitivity reactions article](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398) published in the August 2013 issue of the bulletin. The article advised that an initial test dose on first use of an IV iron product for a new patient is no longer recommended; all references to this recommendation will be removed from relevant product information. However, the article has been updated to clarify that the advice for administration of a product remains otherwise unchanged. For example, for iron dextrans (CosmoFer), a slower rate of administration for the first 25 mg of iron is required for every dose.\n\nThe article can be found [here](http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300398). If you read, downloaded, or shared the article before the update on Sept 9, 2013, please revisit the article to ensure that you have the most up to date information.\n\n \n\nArticle citation: Drug Safety Update September 2013 volume 7, issue 2: O1.\n"
}